We could speculate that TMEM2 could be extremely important in cancers with a pericellular coat made of HA, for example in ovarian cancer, where this localization “suggests a pivotal role of the CD44-HA signaling axis for malignant progression in ovarian cancer” [4]. Here, CEMIP2 is linked to ovarian cancer.